Jun 08, 2021 / 01:00PM GMT
Operator
Good morning and good afternoon, and welcome to the Novartis Oncology Update. (Operator Instructions) And the conference is being recorded. (Operator Instructions) A recording of the conference call, including the Q&A session, will be available on our website shortly after the call ends. (Operator Instructions)
With that, I would like to hand over to Mr. Samir Shah, Head of Investor Relations. Please go ahead, sir.
Samir Shah - Novartis AG - Global Head of IR
Thank you and good morning and good afternoon, everybody. Thank you so much for taking the time to join us today. We appreciate it's a really busy time especially today with the various investor-related calls. It's my pleasure to have with us today, as we go through the key highlights from ASCO, Susanne Schaffert, who's the President of Novartis Oncology; Alice Shaw, Global Head of Translational Clinical Oncology at the Novartis Institute of Biomedical Research; Sidonie Daffner, who's the President of Radioligand Therapies; and Jeff Legos, the Global Head of Oncology Development within Novartis
Novartis AG Oncology Update Call Transcript
Feb 11, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers